Treatment with a nucleoside polymerase inhibitor reduces shedding of murine norovirus in stool to undetectable levels without emergence of drug-resistant variants

Rocha-Pereira, J., Van Dycke, J., & Neyts, J.

Antimicrobial agents and chemotherapy, 60(3), 1907-1911.

Prolonged norovirus shedding may occur in certain patients, such as organ transplant recipients. We established a mouse model for persistent norovirus infection (using the mouse norovirus MNV.CR6 strain). The nucleoside viral polymerase inhibitor 2′-C-methylcytidine (2CMC), but not favipiravir (T-705), reduced viral shedding to undetectable levels. Viral rebound was observed after stopping treatment, which was again effectively controlled by treatment with 2CMC. No drug-resistant variants emerged.

Treatment-with-a-nucleoside-polymerase-inhibitor-reduces-shedding-of-murine-norovirus-in-stool-to-undetectable-levels-without-emergence-of-drug-resistant-variants

Products Used in this Publication

Catalog NumberCASProduct NamePrice
B0084-463609259793-96-9T 705Inquiry

Related Products

Catalog NumberCASProduct NamePrice
3900-49-03900-49-01,6-Dimethoxy naphthaleneInquiry
211513-37-0211513-37-0DalcetrapibInquiry
B0084-462269958002-36-3BMS-791325 HClInquiry
1026785-55-61026785-55-6LomibuvirInquiry